1. Home
  2. DERM vs RILY Comparison

DERM vs RILY Comparison

Compare DERM & RILY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DERM
  • RILY
  • Stock Information
  • Founded
  • DERM 2014
  • RILY 1973
  • Country
  • DERM United States
  • RILY United States
  • Employees
  • DERM N/A
  • RILY N/A
  • Industry
  • DERM Biotechnology: Pharmaceutical Preparations
  • RILY Investment Managers
  • Sector
  • DERM Health Care
  • RILY Finance
  • Exchange
  • DERM Nasdaq
  • RILY Nasdaq
  • Market Cap
  • DERM 190.7M
  • RILY 154.9M
  • IPO Year
  • DERM 2021
  • RILY 2007
  • Fundamental
  • Price
  • DERM $7.94
  • RILY $5.18
  • Analyst Decision
  • DERM Strong Buy
  • RILY
  • Analyst Count
  • DERM 3
  • RILY 0
  • Target Price
  • DERM $12.67
  • RILY N/A
  • AVG Volume (30 Days)
  • DERM 153.4K
  • RILY 605.0K
  • Earning Date
  • DERM 11-07-2025
  • RILY 11-13-2025
  • Dividend Yield
  • DERM N/A
  • RILY N/A
  • EPS Growth
  • DERM N/A
  • RILY N/A
  • EPS
  • DERM N/A
  • RILY N/A
  • Revenue
  • DERM $56,397,000.00
  • RILY $639,161,000.00
  • Revenue This Year
  • DERM $26.16
  • RILY N/A
  • Revenue Next Year
  • DERM $45.27
  • RILY N/A
  • P/E Ratio
  • DERM N/A
  • RILY N/A
  • Revenue Growth
  • DERM N/A
  • RILY N/A
  • 52 Week Low
  • DERM $3.54
  • RILY $2.67
  • 52 Week High
  • DERM $8.90
  • RILY $7.90
  • Technical
  • Relative Strength Index (RSI)
  • DERM 66.43
  • RILY 45.89
  • Support Level
  • DERM $7.38
  • RILY $4.98
  • Resistance Level
  • DERM $8.20
  • RILY $5.77
  • Average True Range (ATR)
  • DERM 0.36
  • RILY 0.33
  • MACD
  • DERM 0.09
  • RILY -0.00
  • Stochastic Oscillator
  • DERM 93.80
  • RILY 41.69

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

About RILY B. Riley Financial Inc.

B. Riley Financial Inc is a diversified financial services company. The company through its subsidiaries offers investment banking and financial services to corporate, institutional, and high-net-worth clients and also asset disposition, valuation and appraisal, and capital advisory services to retail, wholesale, institutional, lenders, capital providers, private equity investors, and professional services firms in United States, Canada, and Europe. It also provides internet access and subscription services. The reportable operating segments of the company include Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications segment, and Consumer products segment.

Share on Social Networks: